e-learning
resources
Milan 2017
Tuesday, 12.09.2017
COPD: latest insights into the management of patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What does endotyping mean for treatment?
A. Agusti Garcia-Navarro (Barcelona, Spain)
Source:
International Congress 2017 – COPD: latest insights into the management of patients
Session:
COPD: latest insights into the management of patients
Session type:
Lunchtime session
Number:
4314
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Agusti Garcia-Navarro (Barcelona, Spain). What does endotyping mean for treatment?. International Congress 2017 – COPD: latest insights into the management of patients
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Response: The most fundamental change in asthma management in 30 years?
Source: Eur Respir J, 54 (5) 1901860; 10.1183/13993003.01860-2019
Year: 2019
How often do asthma patients claim prescribed therapy?
Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Year: 2017
COPD: more treatments but no cure?
Source: Annual Congress 2011 - The European Respiratory Review 2010 updates: whats hot in pulmonary medicine?
Year: 2011
Use of alternative therapies in patients with asthma and COPD: is there any difference?
Source: Eur Respir J 2005; 26: Suppl. 49, 504s
Year: 2005
Cleaning agents and asthma: what does the evidence currently tell us about diagnosis and management of these cases?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018
How much is too much? The treatment of mild asthma
Source: Eur Respir J 2007; 30: 403-406
Year: 2007
The most fundamental change in asthma management in 30 years?
Source: Eur Respir J, 54 (5) 1901583; 10.1183/13993003.01583-2019
Year: 2019
Managing asthma patients: which outcomes matter?
Source: Eur Respir Rev 2008; 17: 53-61
Year: 2008
Combination therapy versus separate therapy in real-life primary care asthma patients
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
Overweight children with asthma - are attribution of symptoms and treatment regimens appropriate?
Source: Eur Respir J 2002; 20: Suppl. 38, 333s
Year: 2002
Does combination therapy lead to better adherence in asthma?
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Is there a benefit of an additive standard immunoglobulin therapy for the clinical course of COPD patients under chronic immunosuppressive therapy?
Source: Eur Respir J 2001; 18: Suppl. 33, 24s
Year: 2001
The future: treating specific endotypes
Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2016
The future: treating specific endotypes
Source: International Congress 2015 – PG2 Asthma and COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept